- Home
- ACIU vs NRDY Comparison
ACIU vs NRDY Comparison
Compare ACIU & NRDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- NRDY
- Stock Information
- Founded
- ACIU 2003
- NRDY 2007
- Country
- ACIU Switzerland
- NRDY United States
- Employees
- ACIU N/A
- NRDY N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- NRDY Computer Software: Prepackaged Software
- Sector
- ACIU Health Care
- NRDY Technology
- Exchange
- ACIU Nasdaq
- NRDY Nasdaq
- Market Cap
- ACIU 270.1M
- NRDY 225.1M
- IPO Year
- ACIU 2016
- NRDY N/A
- Fundamental
- Price
- ACIU $2.65
- NRDY $1.66
- Analyst Decision
- ACIU Strong Buy
- NRDY Hold
- Analyst Count
- ACIU 2
- NRDY 8
- Target Price
- ACIU $12.00
- NRDY $2.35
- AVG Volume (30 Days)
- ACIU 203.0K
- NRDY 1.1M
- Earning Date
- ACIU 03-13-2025
- NRDY 02-27-2025
- Dividend Yield
- ACIU N/A
- NRDY N/A
- EPS Growth
- ACIU N/A
- NRDY N/A
- EPS
- ACIU N/A
- NRDY N/A
- Revenue
- ACIU $48,505,404.00
- NRDY $197,325,000.00
- Revenue This Year
- ACIU $86.78
- NRDY N/A
- Revenue Next Year
- ACIU $118.22
- NRDY $2.86
- P/E Ratio
- ACIU N/A
- NRDY N/A
- Revenue Growth
- ACIU 4097200.00
- NRDY 9.55
- 52 Week Low
- ACIU $2.25
- NRDY $0.73
- 52 Week High
- ACIU $4.98
- NRDY $3.28
- Technical
- Relative Strength Index (RSI)
- ACIU 47.51
- NRDY 41.30
- Support Level
- ACIU $2.39
- NRDY $1.77
- Resistance Level
- ACIU $2.74
- NRDY $2.02
- Average True Range (ATR)
- ACIU 0.14
- NRDY 0.12
- MACD
- ACIU 0.01
- NRDY -0.03
- Stochastic Oscillator
- ACIU 56.52
- NRDY 5.26
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its purpose-built proprietary platform leverages technology, including AI, to connect learners of all ages to experts, delivering superior value on both sides of the network. Its comprehensive learning destination provides learning experiences across various subjects and multiple formats including one-on-one instruction, small group classes, large format group classes, and adaptive self-study.